Academic Emergency Medicine · 2021 · 20 citations · 34 references
PharmacyEmergency MedicineHospital PharmacyEmergencyEmergency Medical Services EducationSubstance Use DisordersDrug Overdose ManagementDrug Overdose PreventionNaloxone TherapyOpioid ManagementOverdose ManagementOverdose PreventionAcute Care PathwaysEducational ProgramsEmergency Naloxone UseNaloxone ImplementationNaloxone Rescue KitsOpioid Overdose ManagementOverdose Prevention TrainingProvider Education On Opioid Safety
BACKGROUND: Emergency department (ED) patients with nonfatal opioid overdose are at high risk for subsequent fatal overdose, yet ED programs aimed at reducing harm from opioid use remain underdeveloped. OBJECTIVES: The objective was to pilot a statewide ED take-home naloxone program and improve the care of patients with opioid use disorder (OUD) and risky drug use through training and interprofessional network building. METHODS: Nine hospital EDs with pharmacy, nurse, and physician champions were recruited, surveyed, and trained. Take-home naloxone rescue kits were developed, disseminated, and tracked. Two overdose prevention summits were convened prior to the COVID pandemic, and two X-waiver training courses aimed at emergency physicians and advanced practice providers were arranged, both in person and virtual. RESULTS: A total of 872 naloxone rescue kits were distributed to ED patients at risk of opioid overdose during the first phase of this project, and more than 140 providers were trained in the use of medications for OUD in acute care settings. CONCLUSIONS: A statewide ED take-home naloxone program was shown to be feasible across a range of different hospitals with varying maturity in preexisting OUD resources and capabilities. Future work will be aimed at both expanding and measuring the effectiveness of this work.
34
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
Sarah E. Wakeman, Marc R. Larochelle, Omid Ameli et al. · JAMA Network Open · 2020 · 975 citations · Full text
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
Gail D’Onofrio, Patrick G. O’Connor, Michael V. Pantalon et al. · JAMA · 2015 · 904 citations · Full text
Kristin M. Holland, Christopher M. Jones, Alana M. Vivolo‐Kantor et al. · JAMA Psychiatry · 2021 · 595 citations · Full text
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Pooja Lagisetty, Ryan Ross, Amy S. B. Bohnert et al. · JAMA Psychiatry · 2019 · 468 citations · Full text
Greg Ogrinc, Susan Mooney, Carlos A. Estrada et al. · BMJ Quality & Safety · 2008 · 445 citations · Full text